Biosynthesis of mupirocin by pseudomonas fluorescens NCIMB 10586 involves parallel pathways

  • Shu Shan Gao
  • , Joanne Hothersall
  • , Ji'En Wu
  • , Annabel C. Murphy
  • , Zhongshu Song
  • , Elton R. Stephens
  • , Christopher M. Thomas
  • , Matthew P. Crump
  • , Russell J. Cox
  • , Thomas J. Simpson*
  • , Christine L. Willis
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

Mupirocin, a clinically important antibiotic produced via a trans-AT Type I polyketide synthase (PKS) in Pseudomonas fluorescens, consists of a mixture of mainly pseudomonic acids A, B, and C. Detailed metabolic profiling of mutant strains produced by systematic inactivation of PKS and tailoring genes, along with re-feeding of isolated metabolites to mutant stains, has allowed the isolation of a large number of novel metabolites, identification of the 10,11-epoxidase, and full characterization of the mupirocin biosynthetic pathway, which proceeds via major (10,11-epoxide) and minor (10,11-alkene) parallel pathways.

Original languageEnglish
Pages (from-to)5501-5507
Number of pages7
JournalJournal of the American Chemical Society
Volume136
Issue number14
Early online date27 Mar 2014
DOIs
Publication statusPublished - 9 Apr 2014

ASJC Scopus subject areas

  • General Chemistry
  • Catalysis
  • Biochemistry
  • Colloid and Surface Chemistry
  • General Medicine

Fingerprint

Dive into the research topics of 'Biosynthesis of mupirocin by pseudomonas fluorescens NCIMB 10586 involves parallel pathways'. Together they form a unique fingerprint.

Cite this